About Altru Clinical Research
Collaboration. Innovation. Accuracy.

Therapeutic experience
Altru Clinical Research has broad experience covering a myriad of therapeutic areas, including:
Cardiovascular
Heart Failure
Cardiovascular
Dermatology
Acne
Atopic Dermatitis
Device
Diagnostics (imaging, IVD, EEG, ECG, EKG)
Implantable Devices
AI driven
Pulmonary valves
Pulse Monitors
Combination Drug/Device
Infectious Disease
Sepsis
Vaccines
Fungal Infections
Oncology
CAR-T
Immunotherapies
Solid Tumors
Rare Diseases
Multiple
Pain
Autoimmune
Psoriasis
Rheumatoid Arthritis
Endocrine/Hepatology
Diabetes
NASH
Obesity
Polycystic Kidney Disease
Respiratory
Asthma
COPD
COVID-19
Our Mission
Empowering ethical clinical research through tailored, data-driven solutions for the benefit of patients everywhere.
Our Vision
To reshape the future of clinical research by empowering teams with accurate data, cutting-edge tools, and a shared commitment to human health.
Altruistic Core Values

Collaboration
Your success is our priority. Our seasoned experts treat every project as a true partnership, working closely with your team to ensure every contribution drives maximum impact. Through strong collaboration, we help turn collective efforts into exceptional results.

Innovation
We understand that every clinical trial faces tight timelines and budget constraints. That’s why our experts bring a flexible, solutions-oriented mindset—delivering tailored support to help you navigate challenges efficiently and achieve meaningful results.

Accuracy
Your research results matter—not just now, but long into the future. That’s why we prioritize accuracy and integrity in every step of the process. When you partner with us, you can trust that the data we deliver is reliable, precise, and built to stand the test of time.
Meet the Altru Leadership Team of Experts

Veronica L. Bubb, DBA, MS , MAS,
President & Principal Biostatistical Consultant
A seasoned clinical research executive with expertise in biostatistics,
leadership, and team building. Dr. Bubb has contributed to over 100
therapeutic product developments and led regulatory submissions (e.g.,
IND, NDA, BLA, 510k). She has extensive experience across therapeutic
areas and has served on monitoring committees (DMC, SMC, DSMB) in
various capacities.

Lori A. Davis, Ph.D.,
Vice President of Biostatistical Consulting
An accomplished biostatistics leader with over 25 years of experience across clinical research organizations, biotech firms, and independent consulting. Lori has served in senior roles at various companies, specializing in statistical consulting and the development of innovative designs. She has contributed to projects across diverse therapeutic areas, including oncology and rare diseases, and has a proven track record in supporting regulatory submissions and advancing drug development
initiatives.

Sarah L. Landenwitsch, MSPH,
Director of Statistical Programming

Trust ACR with your research.